Literature DB >> 23335160

Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Rasoul Ghasemi1, Leila Dargahi, Ali Haeri, Maryam Moosavi, Zahurin Mohamed, Abolhassan Ahmadiani.   

Abstract

Arduous efforts have been made in the last three decades to elucidate the role of insulin in the brain. A growing number of evidences show that insulin is involved in several physiological function of the brain such as food intake and weight control, reproduction, learning and memory, neuromodulation and neuroprotection. In addition, it is now clear that insulin and insulin disturbances particularly diabetes mellitus may contribute or in some cases play the main role in development and progression of neurodegenerative and neuropsychiatric disorders. Focusing on the molecular mechanisms, this review summarizes the recent findings on the involvement of insulin dysfunction in neurological disorders like Alzheimer's disease, Parkinson's disease and Huntington's disease and also mental disorders like depression and psychosis sharing features of neuroinflammation and neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335160     DOI: 10.1007/s12035-013-8404-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  271 in total

1.  The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.

Authors:  T Sumiyoshi; J Ichikawa; H Y Meltzer
Journal:  Neuropsychopharmacology       Date:  1997-03       Impact factor: 7.853

2.  Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Alzheimers Dis       Date:  2006-07       Impact factor: 4.472

3.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

Authors:  Y He; S Appel; W Le
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

4.  Peptide derived from insulin with regulatory activity of dopamine transporter.

Authors:  Z Liu; Y Wang; W Zhao; J Ding; Z Mei; L Guo; D Cui; J Fei
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

5.  Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease.

Authors:  Francisco J Gil-Bea; Maite Solas; Alina Solomon; Carmen Mugueta; Bengt Winblad; Miia Kivipelto; Maria J Ramirez; Angel Cedazo-Mínguez
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

Review 7.  The relationship between diabetes mellitus and Parkinson's disease.

Authors:  R Sandyk
Journal:  Int J Neurosci       Date:  1993 Mar-Apr       Impact factor: 2.292

8.  Insulin inhibits amyloid beta-induced cell death in cultured human brain pericytes.

Authors:  Annemieke A M Rensink; Irene Otte-Höller; Roelie de Boer; Remko R Bosch; Hans J ten Donkelaar; Robert M W de Waal; Marcel M Verbeek; Berry Kremer
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

9.  Long-chain polyunsaturated fatty acids modulate interleukin-1beta-induced changes in behavior, monoaminergic neurotransmitters, and brain inflammation in rats.

Authors:  Cai Song; Mehar S Manku; David F Horrobin
Journal:  J Nutr       Date:  2008-05       Impact factor: 4.798

10.  GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.

Authors:  Christopher J Phiel; Christina A Wilson; Virginia M-Y Lee; Peter S Klein
Journal:  Nature       Date:  2003-05-22       Impact factor: 49.962

View more
  31 in total

Review 1.  Role of Adiposity-Driven Inflammation in Depressive Morbidity.

Authors:  Lucile Capuron; Julie Lasselin; Nathalie Castanon
Journal:  Neuropsychopharmacology       Date:  2016-07-11       Impact factor: 7.853

Review 2.  Crosstalk between insulin and Toll-like receptor signaling pathways in the central nervous system.

Authors:  Fatemeh Hemmati; Rasoul Ghasemi; Norlinah Mohamed Ibrahim; Leila Dargahi; Zahurin Mohamed; Azman Ali Raymond; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

3.  The SAMP8 mouse for investigating memory and the role of insulin in the brain.

Authors:  Elizabeth M Rhea; William A Banks
Journal:  Exp Gerontol       Date:  2016-12-12       Impact factor: 4.032

4.  GLP-1 receptor agonists for Parkinson's disease.

Authors:  Caroline A Mulvaney; Gonçalo S Duarte; Joel Handley; David Jw Evans; Suresh Menon; Richard Wyse; Hedley Ca Emsley
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23

Review 5.  Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.

Authors:  Therese S Salameh; Elizabeth M Rhea; William A Banks; Angela J Hanson
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

6.  Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease.

Authors:  Shize Li; Nini Wang; Jiyu Lou; Xiaoman Zhang
Journal:  Exp Ther Med       Date:  2015-03-27       Impact factor: 2.447

Review 7.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

Review 8.  Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.

Authors:  Trevor Archer; Serafino Ricci; Danilo Garcia; Max Rapp Ricciardi
Journal:  Neurotox Res       Date:  2014-05-08       Impact factor: 3.911

9.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

10.  The Interplay of Akt and ERK in Aβ Toxicity and Insulin-Mediated Protection in Primary Hippocampal Cell Culture.

Authors:  Rasoul Ghasemi; Maryam Moosavi; Asadollah Zarifkar; Karim Rastegar; Nader Maghsoudi
Journal:  J Mol Neurosci       Date:  2015-08-13       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.